Jackson Acquisition Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RJAC research report →
Price Chart
About the company
Jackson Acquisition Company functions as a Special Purpose Acquisition Company (SPAC). Its primary objective is to execute a strategic business combination—such as a merger, share exchange, asset acquisition, stock purchase, or reorganization—with one or more operating entities. This acquisition strategy is specifically directed towards businesses within the healthcare services and healthcare technology sectors.
- CEO
- Richard Lee Jackson
- IPO
- 2022
- HQ
- Alpharetta, GA, US
Get TickerSpark's AI analysis on RJAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $288.97M
- P/E
- 19.98
- PEG
- -0.94
- P/S
- 0.00
- P/B
- 1.31
- EV/EBITDA
- -24.61
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5.64%
- ROIC
- 5.03%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-25,112,000+0.0%
- Op Income
- $12.09M
- Net Income
- $11.48M-4.7%
- EPS
- $0.52-11.9%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $10.72
- 52W Low
- $9.79
- 50D MA
- $10.35
- 200D MA
- $10.14
- Beta
- 0.00
- RSI (14)
- 64
- Avg Volume
- 86.13K
No earnings-call transcripts are available for RJAC yet.
- Free Float
- 74.3%
- Shares Outstanding
- 27.81M
- Float Shares
- 20.66M
of shares held by institutions
57 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 400.00K | ▲ 400.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 8, 21 | Jackson Richard Lee | other | 5,635,000 |
| Dec 8, 21 | TAVENNER MARILYN B | other | 25,000 |
| Dec 8, 21 | Migoya Carlos A | other | 25,000 |
| Dec 8, 21 | Migoya Carlos A | other | 25,000 |
| Dec 8, 21 | Kline Douglas B | other | 15,000 |
| Dec 8, 21 | Bush John Ellis | other | 0 |
| Dec 8, 21 | PERDUE DAVID A | other | 50,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RJAC coverage
Recent articles, reports, and earnings notes.
No research on RJAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RJAC report →